Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A microneedle patch for facial sebum reduction (split-face pilot trial)
TCTR20260401021Phase 2Not yet recruiting
- Sponsor
- N/A
- Start
- Mar 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in seborrheic dermatitis (SD), sponsored by N/A. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on TCTR20260401021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260401021.